More Favorable Short and Long-Term Outcomes for Screen-Detected Colorectal Cancer PatientsGaya Spolverato, Massimo Rugge, Fabio Ceccato et al.|Frontiers in Oncology|2021Cited by 15
IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancerOttavia De Simoni, Chiara Cipollari, Melania Scarpa et al.|Cancer|2024Cited by 8
68 IMMUNOREACT 13: IMMUNE SURVEILLANCE MARKERS IN THE CLINICAL MANAGEMENT OF STAGE II RECTAL CANCERGiorgio Rivella, Marco Scarpa, Melania Scarpa et al.|Gastroenterology|2024Cited by 0
IMMUNOREACT 9 metachronous rectal cancers have high HLA-ABC expression on healthy epithelium but a lower infiltration of CD3+ T cells than primary lesionsBeatrice Salmaso, Alessandra Piccioli, Melania Scarpa et al.|Scientific Reports|2024Cited by 0
Gut microbiota-associated predictors as biomarkers of neoadjuvant treatment response in rectal cancer-a systematic reviewAstghik Stepanyan, Licia Laurino, Andromachi Kotsafti et al.|British Journal of Cancer|2026Cited by 0